BGL, a founding sponsor and Knowledge Partner of the DxPx franchise, an annual international partnering conference designed to facilitate licensing, financing, co-development, and M&A opportunities, is proud to support DxPx EU again this year.
For the first time, this year’s DxPx EU conference will take place on October 5th in Munich, Germany, adjacent to Oktoberfest.
BGL Managing Director Christoph Brandenberger will be moderating the 1st Annual Late-Stage Forum, an exclusive gathering of industry-focused private equity investors and late-stage health tech and life sciences companies on October 5th at 3 p.m. CET.
BGL’s Diagnostics, Research Tools & Medical Devices team has decades of experience advising all major subsectors of the Diagnostics & Research Tools industry. We maintain active relationships with global industry participants and capital providers and follow regulatory and reimbursement trends; this enables us to not only provide unique access to capital providers, but also the ability to identify and execute on strategic opportunities for our clients.